Decibel Therapeutics, Inc.
NNASDAQ:DBTXCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- Address
- Similar Companies
- Business
Company News
Decibel Therapeutics' CVR Appears Around Fair Value
DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX
DECIBEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Decibel Therapeutics, Inc. - DBTX
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update
Decibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals
Shareholder Alert: Ademi LLP investigates whether Decibel Therapeutics, Inc. has obtained a Fair Price in its transaction with Regeneron
DBTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Decibel Therapeutics, Inc. Is Fair to Shareholders
Decibel Therapeutics (DBTX) Stock Skyrockets 71% on Regeneron Deal
Decibel Therapeutics shoots up 72% on Regeneron bid
Regeneron buying small cap Decibel Therapeutics for $4 a share
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
Decibel Therapeutics to Present at the 46th Annual Association for Research in Otolaryngology (ARO) MidWinter Meeting
Decibel Therapeutics to Participate in Upcoming Investor Conferences
Top Penny Stocks Today? 3 You Might Want To Watch Before Next Week
Decibel Therapeutics Delivers Solid Interim Data From Cisplatin-Associated Hearing Loss Study
Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference
Decibel Therapeutics to Present at the H.C. Wainwright Global Investment Conference
Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting